Skip to main content

Published locations for Olokizumab proves noninferior to adalimumab for RA in phase 3 trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Olokizumab proves noninferior to adalimumab for RA in phase 3 trial

User login

  • Reset your password
  • /content/olokizumab-proves-noninferior-adalimumab-ra-phase-3-trial
  • /familypracticenews/article/257325/rheumatoid-arthritis/olokizumab-proves-noninferior-adalimumab-ra
  • /internalmedicinenews/article/257325/rheumatoid-arthritis/olokizumab-proves-noninferior-adalimumab-ra
  • /rheumatologynews/article/257325/rheumatoid-arthritis/olokizumab-proves-noninferior-adalimumab-ra
  • /rheumatology/article/257325/rheumatoid-arthritis/olokizumab-proves-noninferior-adalimumab-ra-phase-3
  • /internalmedicine/article/257325/rheumatoid-arthritis/olokizumab-proves-noninferior-adalimumab-ra
  • /familymedicine/article/257325/rheumatoid-arthritis/olokizumab-proves-noninferior-adalimumab-ra-phase